Plasma osteopontin is not associated with vascular markers of subclinical atherosclerosis in a population of young adults without symptoms of cardiovascular disease. The Cardiovascular Risk in Young Finns Study

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 71, Issue 8, 2011, Pages 683-689

  Wendelin Saarenhovi, Maria ^a,b   Oikonen, Mervi ^b   Loo, Britt Marie ^c   Juonala, Markus ^b   Kähönen, Mika ^d   Viikari, Jorma S A ^a   Raitakari, Olli T ^a,b  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

cohort study; Epidemiology; inflammation; osteopontin; risk factors

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; CHOLESTEROL; INSULIN; OSTEOPONTIN; SEX HORMONE BINDING GLOBULIN;

ADULT; ALCOHOL CONSUMPTION; ARTERIAL WALL THICKNESS; ARTERY ENDOTHELIUM; ARTERY LESION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; MALE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; FINLAND; HUMANS; MALE; OSTEOPONTIN; RISK FACTORS; SEX FACTORS; TUNICA INTIMA;

EID: 81255128861     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2011.621027     Document Type: Article

References (27)

1. Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, et al. Relationship between C-reactive protein and subclinical atherosclerosis: The Dallas Heart Study. Circulation 2006;113:38-43.
2. Miller M, Zhan M, Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: The Third National Health and Nutrition Examination Survey. Arch Intern Med 2005;165:2063-8.
3. Brevetti G, Giugliano G, Brevetti L, Hiatt WR. Infl ammation in peripheral artery disease. Circulation 2010;122: 1862-75.
4. Ohmori R, Momiyama Y, Taniguchi H, Takahashi R, Kusuhara M, Nakamura H, Ohsuzu F. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003;170:333-7.
5. Cho HJ, Cho HJ, Kim HS. Osteopontin: A multifunctional protein at the crossroads of infl ammation, atherosclerosis, and vascular calcifi cation. Curr Atheroscler Rep 2009;11: 206-13.
6. Scatena M, Liaw L, Giachelli CM. Osteopontin: A multifunctional molecule regulating chronic infl ammation and vascular disease. Arterioscler Thromb Vasc Biol 2007;27: 2302-9.
7. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcifi cation in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994; 94:1597-1604.
8. Momiyama Y, Ohmori R, Fayad ZA, Kihara T, Tanaka N, Kato R, et al. Associations between plasma osteopontin levels and the severities of coronary and aortic atherosclerosis. Atherosclerosis 2010;210:668-70.
9. Waller AH, Sanchez-Ross M, Kaluski E, Klapholz M. Osteopontin in cardiovascular disease: A potential therapeutic target. Cardiol Rev 2010;18:125-31.
10. Raitakari OT, Juonala M, Kä hön en M, Taittonen L, Laitinen T, Mä ki-Torkko N, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: The Cardiovascular Risk in Young Finns Study. JAMA 2003;290:2277-83.
11. Juonala M, Viikari JS, Kä hön en M, Solakivi T, Helenius H, Jula A,et al. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: The Cardiovascular Risk in Young Finns Study. J. Am. Coll. Cardiol. 2008;52: 293-9.
12. K urata M, Okura T, Watanabe S, Fukuoka T, Higaki J. Osteopontin and carotid atherosclerosis in patients with essential hypertension. Clin Sci (Lond) 2006;111: 319-24.
13. Telama R, Yang X, Viikari J, Vä l imäk i I, Wanne O, Raitakari O. Physical activity from childhood to adulthood: A 21-year tracking study. Am. J. Prev Med 2005;28:267-73.
14. Raiko JR, Viikari JS, Ilmanen A, Hutri-Kä hön en N, Taittonen L, Jokinen E, et al. Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors. J Intern Med 2010;267: 370-84.
15. Saarikoski LA, Huupponen RK, Viikari JS, Marniemi J, Juonala M, Kä hönen M, Raitakari OT. Adiponectin is related with carotid artery intima-media thickness and brachial fl ow-mediated dilatation in young adults - the Cardiovascular Risk in Young Finns Study. Ann Med 2010; 42:603-11.
16. Juonala M, Viikari JSA, Laitinen T, Marniemi J, Helenius H, Rönnemaa T, Raitakari OT. Interrelations between brachial endothelial function and carotid intima-media thickness in young adults. The Cardiovascular Risk in Young Finns Study. Circulation 2004;110:2918-23.
17. Ishiyama M, Suzuki E, Katsuda J, Murase H, Tajima Y, Horikawa Y, et al. Associations of coronary artery calcifi - cation and carotid intima-media thickness with plasma concentrations of vascular calcifi cation inhibitors in type 2 diabetic patients. Diabetes Res Clin Pract 2009;85: 189-96.
18. Pepys MD. C-reactive protein. In: Delves PJ, Roitt IM, editors. Encyclopedia of immunology, 2nd ed. San Diego, CA: Academic Press, 1988. pp. 663 - 5.
19. Pepys MB, Hirschfi eld GM. C-reactive protein: A critical update. J Clin Invest 2003;111:1805-12.
20. Lorenz MW, Karbstein P, Markus HS, Sitzer M. Highsensitivity C-reactive protein is not associated with carotid intima-media progression: The carotid atherosclerosis progression study. Stroke 2007;38:1774-9.
21. Nordestgaard BG, Zachoa J. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander? Nutrition, Metabolism Cardiovasc Dis 2009;19:521-4.
22. Abdel-Azeez HA, Al-Zaky M. Plasma osteopontin as a predictor of coronary artery disease: Association with echocardiographic characteristics of atherosclerosis. J Clin Lab Anal 2010;24:201-6.
23. Calderon-Margalit R, Schwartz SM, Wellons MF, Lewis CE, Daviglus ML, et al. Prospective association of serum androgens and sex hormone-binding globulin with subclinical cardiovascular disease in young adult women: The ' Coronary Artery Risk Development in Young Adult Women ' s study. J. Clin. Endocrinol. Metab. 2010;95:4424-31.
24. Brand JS, van der Tweel I, Grobbee DE, Emmelot-Vonk MH, van der Schouw YT. Testosterone, sex hormone-binding globulin and the metabolic syndrome: A systematic review and meta-analysis of observational studies. Int J Epidemiol 2011;40:189-207.
25. Kurata M, Okura T, Irita J, Enomoto D, Nagao T, Jotoku M, Miyoshi K, Higaki J. The relationship between osteopontin and adiponectin in patients with essential hypertension. Clin Exp Hypertens 2010;32:358-63.
26. Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima- media thickness: A systematic review and meta-analysis. Circulation 2007;115:459-67.
27. Georgiadou P, Iliodromitis EK, Kolokathis F, Varounis C, Gizas V, Mavroidis M, et al. Osteopontin as a novel prognostic marker in stable ischaemic heart disease: A 3-year follow-up study. Eur. J. Clin Invest 2010;40:288-93.